India  

Good immune response from Covishield & Covaxin: Study

IndiaTimes Sunday, 6 June 2021
A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and prevent serious disease in those infected after immunisation. Interestingly, the Oxford vaccine Covishield could generate antibodies in more individuals compared to Bharat Biotech’s Covaxin, a pre-print of the first such Indian study has stated. Most vaccine efficacy studies so far have been lab-based.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News

AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News 01:46

According to separate studies by AIIMS and the National Centre for Disease Control, the 'delta' variant of COVID-19 is capable of infecting people even after they have received both doses of the Covaxin or Covishield vaccines. It is important to note that neither study has been peer-reviewed as...

You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News [Video]

UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News

The UK has revised its travel policy to include Covishield as an approved vaccine after a furious India warned of ‘reciprocal measures’, but Indians double-vaccinated with the shot still have to quarantine. #UKVaccinePolicy #CoWin #Covishield

Credit: Oneindia    Duration: 01:40Published

Covishield approved in UK, travel advisory revised after strong objections from India

The UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory.
DNA

India warns UK of reciprocal steps over vaccine ‘discrimination’

“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing..
IndiaTimes

Covaxin Covaxin Vaccine against COVID-19

Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairman

Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
IndiaTimes

Covaxin may soon get WHO approval as expert group scheduled to meet next month

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
DNA

Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK Paul

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
DNA

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer


Related videos from verified sources

Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, According to Study [Video]

Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, According to Study

Pfizer and Moderna Vaccines Likely to Produce, Lasting Immunity, According to Study. A recent study found that the Pfizer-BioNTech and Moderna vaccines create a persistent immune reaction, . which..

Credit: Wibbitz Top Stories     Duration: 00:56Published

Related news from verified sources

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 cror

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 cror
The Department of Biotechnology has given permission to HBPCL for producing Covaxin under Mission Covid Suraksha. Covaxin has been developed by Bharat Biotech in...
Mid-Day

Good immune response from Covishield & Covaxin: Study

A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and...
IndiaTimes

Brazil regulator grants GMP certification to Bharat Biotech's Covaxin facilities

Less than a week after Brazil’s health regulator green-lighted the “exceptional import” of 4 million doses of Bharat Biotech’s Covid-19 jab Covaxin, it...
IndiaTimes